← Back to Clinical Trials
Recruiting NCT05371106

NCT05371106 Mycotoxins in Mothers Milk in Israel

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05371106
Status Recruiting
Phase
Sponsor Assaf-Harofeh Medical Center
Condition Breastfeeding
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2020-09-01
Primary Completion 2027-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 55 Years
Study Type OBSERVATIONAL
Interventions
exposure to mycotoxins

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2020-09-01 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Some plant pathogen fungi may develop in grains, nuts and dry foodstuff during their storage. They secrete toxins which are very resistant and persistent. The toxins enter the human body through the food. Women eating without their knowledge spoiled food absorb the toxin which is conveyed into their milk. In the same way, meat and dairy products can be contaminated with mycotoxins. Toxins and their metabolites can have negative effects on pregnant women and on the fetus or infant health. The main purpose of this trial is to assess the presence of toxins in mothers's milk.

Eligibility Criteria

Inclusion Criteria: * Women aged 18 and above. * Pregnant women after week 37 intending to breastfeed. * Women breastfeeding. Exclusion Criteria: * Women taking drugs which influence milk production. * Women taking drugs contraindicated during breastfeeding. * Women not staying in Israel during third trimester or in the months after birth for a long period of time. * Women not wanting/able to fill up the questionnaires.

Contact & Investigator

Central Contact

Elkana Kohn, Ph.D.

✉ elkanak@shamir.gov.il

📞 972-8-9772181

Principal Investigator

Elkana Kohn, Ph.D.

PRINCIPAL INVESTIGATOR

Shamir (Assaf Harofeh) Medical Center

Frequently Asked Questions

Who can join the NCT05371106 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Breastfeeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05371106 currently recruiting?

Yes, NCT05371106 is actively recruiting participants. Contact the research team at elkanak@shamir.gov.il for enrollment information.

Where is the NCT05371106 trial being conducted?

This trial is being conducted at Ẕerifin, Israel.

Who is sponsoring the NCT05371106 clinical trial?

NCT05371106 is sponsored by Assaf-Harofeh Medical Center. The principal investigator is Elkana Kohn, Ph.D. at Shamir (Assaf Harofeh) Medical Center. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology